Novo Nordisk said on Monday it has launched its popular obesity drug Wegovy in China, the world's second-largest ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

About 400 people marched to the South African headquarters of Novo Nordisk A/S in Johannesburg this week demanding greater ...

Novo Nordisk has long supplied human insulin pens to the national health department. But last year it decided not to bid for ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

After rising in premarket trading, Novo Nordisk's U.S.-listed shares fell after the market opened Wednesday as its ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

减重药物Ozempic的升级版 ...

This Score examines things like projected and historical earnings, sales, and cash flow to find stocks that will generate ...

Popular weight-loss drug Wegovy maker Novo Nordisk expects high demand and acceptance for its anti-obesity drug, when ...

Novo Nordisk and Eli Lilly are both raking in billions from their blockbuster weight loss drugs that are also approved to ...

The company narrowed its full-year guidance as its blockbuster weight-loss drug soars in popularity.